Cardlytics, Inc. (CDLX)

Cardlytics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	309.2	298.54	267.12	186.89	210.43
Revenue Growth (YoY)	3.57%	11.76%	42.93%	-11.19%	39.65%
Cost of Revenue	178.83	185.91	163.78	123.62	130.97
Gross Profit	130.38	112.63	103.34	63.27	79.46
Selling, General & Admin	116.24	156.19	132.22	91.84	80.55
Research & Development	51.35	54.44	38.1	17.53	11.7
Other Operating Expenses	90.67	487.96	54.24	7.83	4.54
Operating Expenses	258.25	698.58	224.57	117.2	96.78
Operating Income	-127.87	-585.95	-121.23	-53.92	-17.33
Interest Expense / Income	2.34	2.56	12.56	3.05	0.55
Other Expense / Income	4.49	-121.8	2.64	-1.55	-0.73
Pretax Income	-134.7	-466.71	-136.43	-55.42	-17.14
Income Tax	0	-1.45	-7.86	0	0
Net Income	-134.7	-465.26	-128.57	-55.42	-17.14
Shares Outstanding (Basic)	36	33	32	27	24
Shares Outstanding (Diluted)	36	33	32	27	24
Shares Change	9.18%	3.78%	18.33%	14.60%	24.59%
EPS (Basic)	-3.69	-13.92	-3.99	-2.04	-0.72
EPS (Diluted)	-3.69	-13.92	-3.99	-2.04	-0.72
Free Cash Flow	-12.58	-67.39	-51.09	-17.72	0.44
Free Cash Flow Per Share	-0.34	-2.02	-1.59	-0.65	0.02
Gross Margin	42.17%	37.73%	38.69%	33.86%	37.76%
Operating Margin	-41.36%	-196.27%	-45.38%	-28.85%	-8.23%
Profit Margin	-43.56%	-155.85%	-48.13%	-29.65%	-8.15%
Free Cash Flow Margin	-4.07%	-22.57%	-19.13%	-9.48%	0.21%
EBITDA	-102.85	-420.41	-88.21	-40.78	-12.06
EBITDA Margin	-33.26%	-140.82%	-33.02%	-21.82%	-5.73%
Depreciation & Amortization	29.52	43.74	35.65	11.59	4.54
EBIT	-132.37	-464.15	-123.87	-52.37	-16.6
EBIT Margin	-42.81%	-155.47%	-46.37%	-28.02%	-7.89%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).